Chief executive

Daniel O'Day

Chairman & CEO · Gilead Sciences, Inc.

19 disclosed trades · 30 May 2025 to 1 Oct 2026 · latest filed 2 Oct 2026

Chief executive of Gilead Sciences, Inc. (GILD), tracked from the executive's own SEC Form 4 disclosures.

Recent disclosed trades

19 most recent of 19 trades. Amounts are shares times the reported price. Source: SEC Form 4 filings, filed to 2 Oct 2026.
CompanyTrade dateActionAmountFiled
Common Stock (GILD)2026-10-01Sell$2,218,5082026-10-02
Common Stock (GILD)2026-09-01Sell$2,229,5922026-09-02
Common Stock (GILD)2026-08-03Sell$1,954,6942026-08-04
Common Stock (GILD)2026-07-01Sell$1,894,3992026-07-02
Common Stock (GILD)2026-06-01Sell$1,971,8472026-06-02
Common Stock (GILD)2026-04-28Sell$1,291,6092026-04-29
Common Stock (GILD)2026-03-27Sell$1,368,1622026-03-30
Common Stock (GILD)2026-02-27Sell$1,447,8582026-03-02
Common Stock (GILD)2026-02-05Sell$17,346,0002026-02-06
Common Stock (GILD)2026-01-28Sell$1,398,9112026-01-29
Common Stock (GILD)2026-01-23Sell$15,611,4002026-01-26
Common Stock (GILD)2025-12-29Sell$1,248,2722025-12-30
Common Stock (GILD)2025-11-28Sell$1,265,4442025-12-01
Common Stock (GILD)2025-10-28Sell$1,193,9262025-10-29
Common Stock (GILD)2025-09-29Sell$1,116,5642025-09-30
Common Stock (GILD)2025-08-28Sell$1,136,3002025-08-29
Common Stock (GILD)2025-07-28Sell$1,139,3702025-07-29
Common Stock (GILD)2025-06-30Sell$1,104,4842025-07-01
Common Stock (GILD)2025-05-30Sell$1,104,1932025-06-02

Source: SEC Form 4 filings, trades from 30 May 2025 to 1 Oct 2026, latest filed 2 Oct 2026. Executives report their own trades on Form 4 within two business days.

Open the interactive profile: all trades, compare with others